Clinical Trial Update: Immunoglobulin M (IgM)-Anti-myelin-associated-glycoprotein(MAG) Peripheral Neuropathy Study

View source ↗

Summary

A clinical trial sponsored by Hospices Civils de Lyon evaluating a therapy for IgM anti-MAG peripheral neuropathy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Igm Anti-mag Neuropathy

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Immunoglobin M Anti-myelin-associated-glycoprotein Peripheral Neuropathy | Status: RECRUITING